1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow Aaron Wolfson: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma Lenvatinib, Pembrolizumab, Hypofractionated External Beam Radiation Therapy - Recurrent Endometrial Carcinoma, Unresectable Endometrial Carcinoma | Phase 1 | Recruiting | Aaron Wolfson | 18 | 2023-04-15 | 2026-08-03 |
Brachytherapy (1) · lenvatinib (1) · pembrolizumab (1)
United States (1)